Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$99.73 - $148.48 $4.99 Million - $7.42 Million
-50,000 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$65.07 - $98.24 $6.18 Million - $9.33 Million
-95,000 Reduced 65.52%
50,000 $4.29 Million
Q3 2020

Nov 16, 2020

SELL
$59.04 - $77.95 $15.1 Million - $19.9 Million
-255,000 Reduced 63.75%
145,000 $9.43 Million
Q1 2020

May 13, 2020

BUY
$27.51 - $57.29 $5.5 Million - $11.5 Million
200,000 Added 100.0%
400,000 $13.6 Million
Q3 2019

Nov 14, 2019

BUY
$37.38 - $49.47 $7.48 Million - $9.89 Million
200,000 New
200,000 $8.34 Million

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Nwi Management LP Portfolio

Follow Nwi Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwi Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Nwi Management LP with notifications on news.